June 22, 2012
HOERSHOLM, DenmarkChr. Hansen has signed an agreement with Labroatorios Synthesis, a pharmaceutical company in Columbia, to distribute its female health product INVIMA. INMIVA is a probiotic capsule taken orally that can help reduce the risk of vaginal infections. The product will be sold in Columbia under the brand name "BioBactro." The company recently presented the product at a women's health conference attended by 200 medical doctors in Cartagena, Colombia.
Last year, Chr. Hansen launched a study looking to prove that consuming probiotics helps protect against influenza and the common cold.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Exercise recovery: Electrolytes, hydration and combating fatigue – SupplySide intensive webinarSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023